Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA

• Felipe Ades ,

  * E-mail: felipeades@gmail.com, felipe.ades@einstein.br

  Affiliations Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium, Centro de Oncologia e Hematologia, Hospital Israelita Albert Einstein, São Paulo, Brazil

  http://orcid.org/0000-0002-6074-6133

  ⨯
• Christelle Senterre,

  Affiliation Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Dimitrios Zardavas,

  Affiliation Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium

  ⨯
• Evandro de Azambuja,

  Affiliation Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Razvan Popescu,

  Affiliation Department of Medical Oncology, Hirslanden Clinic Aarau, Aarau, Switzerland

  ⨯
• Martine Piccart

  Affiliation Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

  ⨯